Skip to content

Clinical trials

Phase 3 Premature Birth trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Premature Birth Phase: Phase 3 Country / region: France Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20062
20081
20121
20151
20161
20192
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated2
Active, not recruiting1
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris4
Centre Hospitalier Universitaire, Amiens1
Elgan Pharma Ltd.1
Institut National de la Santé Et de la Recherche Médicale, France1
Nantes University Hospital1
University Hospital, Grenoble1
University Hospital, Strasbourg, France1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Premature Birth10
Bronchopulmonary Dysplasia1
Cross Infection1
Ductus Arteriosus, Patent1
Malabsorption Syndromes1
Mydriasis1
Neutropenia1
Premature Rupture of Fetal Membranes1
Thyroid Diseases1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.